HDAC9 and chronic obstructive pulmonary disease: These effects synergistically enhance the anti-inflammatory properties of cortisol in asthma and chronic obstructive pulmonary disease treatments.425 Nonetheless, a phase III clinical study revealed that additional administration of low-dose theophylline, along with inhaled long-acting β2-agonists and corticosteroids, failed to enhance HDAC activity in vivo.